AMSTERDAM, November 3 /PRNewswire-FirstCall/ --

- University of Miami First Academic Institution in the U.S. to use Scopus Custom Data for Research Measurement

Elsevier, a world-leading publisher of scientific, technical and medical information products and services, announced today its collaboration with the University of Miami for use of Scopus(R) custom data (SCD) at the institution to track and measure faculty research and scholarly activity.

Scopus, the largest abstract and citation database of peer-reviewed literature, was chosen by the University of Miami because the breadth of the content allows the university to accurately capture the greatest amount of faculty research activity from a single data source. This also makes Miami the first academic institution in the United States to use SCD for this type of measurement and tracking.

"We are using Scopus Custom Data to link the University of Miami's unique faculty identifier with the Scopus author ID to better track faculty scholarly activity regardless of the institutional affiliation at the time of publication, " said Jared Abramson, Director, Research Reporting at the University of Miami. "Insight into the expertise of each of our faculty members allows us to promote collaboration, and to build interdisciplinary teams for institutional research projects."

The use of SCD for this type of measurement is increasingly becoming the standard among different institutions. As research continues to become more interdisciplinary and cross-functional, the need for a singular, more accurate and comprehensive research tool, such as Scopus becomes a necessity for academic institutions to remain competitive.

"We are obviously very pleased by how the University of Miami has leveraged Scopus Custom Data through this collaboration" commented Niels Weertman, Director Scopus, Performance & Planning at Elsevier in the Academic & Government Products Group. "And, we see it as a significant step forward in the advancement of research methods and international collaboration."

About Scopus

Covering the world's research literature, Scopus is the largest abstract and citation database of peer-reviewed literature and quality Web sources with smart tools to track analyze and visualize research. Scopus was designed and developed with over 500 users and librarians internationally. Its unique database contains abstracts and references from nearly 18,000 titles from more than 5,000 international publishers, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers users citation information about the articles covered, but also directly integrates Web and patent searches. Direct links to full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool. For more information about Scopus please visit http://www.info.scopus.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell (http://www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and Nursing Consult (http://www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (http://www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Contact:
    Marwa Salem
    Phone: +31-20-485-2674
    E-mail: m.salem@elsevier.com

SOURCE Elsevier